Clinical Trial Update: In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique [Phase 4]

View source ↗

Summary

Phase 4 trial in Mozambique evaluating the in vivo efficacy of four ACT regimens for malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ASAQ (amodiaquine-artesunate)
• Coartem (artemether-lumefantrine)
• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
• Pyramax (pyronaridine-artesunate)

Snippet

Sponsor: Centro de Investigacao em Saude de Manhica | Conditions: Malaria | Phase 4 | Status: COMPLETED